» Authors » Guy B Marks

Guy B Marks

Explore the profile of Guy B Marks including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 298
Citations 20824
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Hansun S, Argha A, Bakhshayeshi I, Wicaksana A, Alinejad-Rokny H, Fox G, et al.
J Med Internet Res . 2025 Mar; 27:e69068. PMID: 40053773
Background: Tuberculosis (TB) remains a significant health concern, contributing to the highest mortality among infectious diseases worldwide. However, none of the various TB diagnostic tools introduced is deemed sufficient on...
2.
Nguyen B, Dang T, Hoang D, Do T, Van Dinh L, Nguyen V, et al.
Trop Med Int Health . 2025 Feb; PMID: 39956136
Background: Drug-related adverse events cause poorer treatment outcomes amongst people with multi-drug-resistant tuberculosis, exacerbating a major global public health problem. The Harnessing new mHealth technologies to Strengthen the Management of...
3.
Landry S, Jamriska M, Menon V, Lee L, Magnin-Bougma I, Subedi D, et al.
J Hazard Mater . 2025 Jan; 487:137211. PMID: 39847930
Mitigation measures against infectious aerosols are desperately needed. We aimed to: 1) compare germicidal ultraviolet radiation (GUV) at 254 nm (254-GUV) and 222 nm (222-GUV) with portable high efficiency particulate...
4.
Zhou Y, Ampon M, Abramson M, James A, Maguire G, Wood-Baker R, et al.
Chron Respir Dis . 2025 Jan; 22:14799731241312687. PMID: 39844530
Individuals with Preserved Ratio Impaired Spirometry (PRISm), defined as FEV/FVC ≥0.7 and FEV1 <80% predicted, are at higher risk of developing COPD. However, data for Australian adults are limited. We...
5.
Duong T, Brigden J, Schaaf H, Garden F, Marais B, Nguyen T, et al.
NEJM Evid . 2024 Dec; 4(1):EVIDoa2400190. PMID: 39693627
Background: Data from randomized trials evaluating the effectiveness of tuberculosis (TB) preventive treatment for contacts of multidrug-resistant (MDR)-TB are lacking. Two recently published randomized trials that did not achieve statistical...
6.
Fox G, Nhung N, Cam Binh N, Hoa N, Garden F, Benedetti A, et al.
N Engl J Med . 2024 Dec; 391(24):2304-2314. PMID: 39693541
Background: Prevention of drug-resistant tuberculosis is a global health priority. However, trials evaluating the effectiveness of treating infection among contacts of persons with drug-resistant tuberculosis are lacking. Methods: We conducted...
7.
Jops P, Cowan J, Nake Trumb R, Kupul M, Kuma A, Bell S, et al.
PLOS Glob Public Health . 2024 Oct; 4(10):e0002572. PMID: 39432474
Combined education and counselling can contribute to person-centred care for tuberculosis (TB), improving uptake, adherence, and outcomes of treatment for TB disease and TB infection. Though strongly recommended by the...
8.
Chatterji M, Donald M, Van Driel M, Marks G, Liaw S, Sharman L
Aust J Gen Pract . 2024 Oct; 53(10):756-763. PMID: 39370163
Background And Objectives: Tuberculosis infection (TBI) screening and treatment delivered from primary care could hold the key to achieving tuberculosis (TB) elimination in low TB burden countries. This scoping review...
9.
Sunjaya A, Poulos L, Di Tanna G, Lung T, Marks G, Reddel H, et al.
Med J Aust . 2024 Aug; 221(6):324-332. PMID: 39193783
Objective: To examine the impact of breathlessness on quality of life, health care use, productivity loss, and economic costs in Australia. Study Design: National internet-based survey of Australian adults drawn...
10.
Chung Y, Garden F, Marks G, Vedam H
BMJ Open Respir Res . 2024 Jul; 11(1). PMID: 39032938
Objective: We sought to describe the long-term prognosis for a population-based cohort of people with hypercapnic respiratory failure (HRF) and the associations between underlying diagnoses and the risks of death...